Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma.

Cancer medicine - 1 Mar 2022

Zhou Wensheng, Liu Zhichao, Wang Yanan, Zhang Yanwei, Qian Fangfei, Lu Jun, Wang Huimin, Gu Ping, Hu Minjuan, Chen Ya, Yang Zhengyu, Zhao Ruiying, Lou Yuqing, Han Baohui, Zhang Wei

Abstract excerpt

BACKGROUND: Epidermal growth factor receptor (EGFR) mutations were frequently found with concomitant genetic alterations in lung adenocarcinoma (LUAD). This study aimed to investigate the profile of concomitant alterations of EGFR-mutant LUAD ≤3 cm in size and its prognostic effect on recurrence. METHODS: From January 2018 to December 2018, patients with resected LUAD ≤3 cm in size in Shanghai Chest Hospital were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Genes, erbB-1

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 35023616
DOI: 10.1002/cam4.4543
PMCID: PMC8894712

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma.PMID 35023616Read ↗

EGFR-mutant lung adenocarcinoma harboring co-mutational tumor suppressor genes predicts poor prognosis.Semantic proximity Read ↗

Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.Semantic proximity Read ↗

Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.Semantic proximity Read ↗

Oncogenic driver mutations in lung cancerSemantic proximity Read ↗

Oncogenic alterations in advanced NSCLC: a molecular super-highwaySemantic proximity Read ↗

Retrospective study on the clinicogenomic characteristics of <i>EGFR</i> mutant and wildtype NSCLCSemantic proximity Read ↗

The co-mutation of EGFR and tumor-related genes leads to a worse prognosis and a higher level of tumor mutational burden in Chinese non-small cell lung cancer patientsSemantic proximity Read ↗

Mutational profiling of lung adenocarcinoma in China detected by next-generation sequencing.Semantic proximity Read ↗

Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Semantic proximity Read ↗

Relationship between driver gene mutations and clinical pathological characteristics in older lung adenocarcinomaSemantic proximity Read ↗

Molecular Epidemiology of the Main Druggable Genetic Alterations in Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Lung Adenocarcinoma: Next Generation Sequencing and Outcome in Regional Community Oncology SettingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.